We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
751
Summit Therapeutics
SMMT
$13.8B
$4.25M 0.01%
544,877
-6,892
-1% -$37.2K
XRAY icon
752
Dentsply Sirona
XRAY
$2.02B
$4.21M 0.01%
169,182
+4,891
+3% +$140K
VICR icon
753
Vicor
VICR
$8.48B
$4.19M 0.01%
+126,417
New +$4.36M
GSK icon
754
GSK
GSK
$101B
$4.16M 0.01%
108,045
-94,223
-47% -$3.96M
NOG icon
755
Northern Oil and Gas
NOG
$2.7B
$4.15M 0.01%
111,744
+10,214
+10% +$410K
WTS icon
756
Watts Water Technologies
WTS
$11.6B
$4.11M 0.01%
22,417
-147
-0.7% -$29.5K
ELS icon
757
Equity Lifestyle Properties
ELS
$11.8B
$4.1M 0.01%
62,948
-672
-1% -$42.1K
PTLO icon
758
Portillo's
PTLO
$270M
$4.06M 0.01%
418,000
+3,600
+0.9% +$40.1K
GPK icon
759
Graphic Packaging
GPK
$2.86B
$4.05M 0.01%
154,553
-6,092
-4% -$168K
VNDA icon
760
Vanda Pharmaceuticals
VNDA
$302M
$4.04M 0.01%
715,645
-25
-0% -$129
PB icon
761
Prosperity Bancshares
PB
$8.45B
$4.04M 0.01%
66,059
+5,920
+10% +$365K
FCF icon
762
First Commonwealth Financial
FCF
$2.14B
$4.03M 0.01%
291,757
+1,850
+0.6% +$24.8K
CMI icon
763
Cummins
CMI
$72.6B
$4.01M 0.01%
14,463
+4,384
+43% +$1.25M
ADSK icon
764
Autodesk
ADSK
$46B
$4M 0.01%
16,163
+15,136
+1,474% +$3.4M
KNSL icon
765
Kinsale Capital Group
KNSL
$8.22B
$4M 0.01%
10,378
-24,405
-70% -$9.91M
OMC icon
766
Omnicom Group
OMC
$21.8B
$3.99M 0.01%
44,489
+10,778
+32% +$1M
APA icon
767
APA Corp
APA
$15.7B
$3.99M 0.01%
135,496
+123,633
+1,042% +$3.83M
ADNT icon
768
Adient
ADNT
$1.41B
$3.98M 0.01%
161,174
-40,888
-20% -$1.16M
SEMR
769
DELISTED
Semrush
SEMR
$3.98M 0.01%
297,311
+236,010
+385% +$3.27M
REGN icon
770
Regeneron Pharmaceuticals
REGN
$79.7B
$3.98M 0.01%
3,784
-6,391
-63% -$6.2M
AEIS icon
771
Advanced Energy
AEIS
$10.1B
$3.97M 0.01%
36,494
+1,050
+3% +$107K
AMAL icon
772
Amalgamated Financial
AMAL
$1.39B
$3.96M 0.01%
144,412
-156
-0.1% -$3.81K
APO.PRA
773
DELISTED
Apollo Global Management Series A
APO.PRA
$3.94M 0.01%
60,000
BWA icon
774
BorgWarner
BWA
$12.7B
$3.92M 0.01%
121,666
-6,459
-5% -$224K
EXTR icon
775
Extreme Networks
EXTR
$2.86B
$3.92M 0.01%
291,245
-192,642
-40% -$2.21M

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.